NCT01246518View on ClinicalTrials.gov

Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

PHASE2CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Onychomycosis

Interventions

DRUG

MOB015

Arm 1; MOB015 once a day for 3 months. Arm 2; MOB015 once a day for 9 months.

Trial Locations (1)

Unknown

15 Locations, Sweden

Sponsors

Lead Sponsor

Moberg Pharma AB

All Listed Sponsors

lead

Moberg Pharma AB

INDUSTRY